Latest Undisclosed Funding Rounds
Funding announcements whose series or stage was not named. Round amounts and investor roles are shown where disclosed.
- Rounds
- 2,305 All time
- Disclosed funding
- $375.2B 1239 disclosed amounts
- Median round
- $8.9M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| C CentivaxCompany profile Develops vaccines and therapies for universal protection against diverse targets Develops vaccines and therapies for universal protection against diverse targets | $37M | Undisclosed | Biotech | United States | Investors | |
| BH Blossom HealthCompany profile AI operating system for psychiatry, providing tools for clinicians and patients AI operating system for psychiatry, providing tools for clinicians and patients | $20M | Seed+Series AUndisclosed | Healthtech | United States | Investors | |
| N NourishAICompany profile NourishAI develops precision nutrition software that combines biological and lifestyle data to support clinicians caring for people with ALS. NourishAI develops precision nutrition software that combines biological and lifestyle data to support clinicians caring for people with ALS. | CHF 100K | i4L Innogrant for BiotherapeuticsUndisclosed | Healthtech | Switzerland | Investors | |
| M MOLECLCompany profile MOLECL develops nanopore-based instruments and software for analysing individual molecules in diagnostics research and biopharmaceutical quality control. MOLECL develops nanopore-based instruments and software for analysing individual molecules in diagnostics research and biopharmaceutical quality control. | CHF 100K | i4L Innogrant for BiotherapeuticsUndisclosed | Biotech | Switzerland | Investors | |
Shield AICompany profile Shield AI develops autonomy software and uncrewed aircraft for military and defense customers. Shield AI develops autonomy software and uncrewed aircraft for military and defense customers. | $500M | Fixed-return preferred equityUndisclosed | Defense tech | United States | Investors Undisclosed | |
| E EleumCompany profile Eleum develops live biotherapeutics that target gut microbial pathways in ulcerative colitis. Eleum develops live biotherapeutics that target gut microbial pathways in ulcerative colitis. | CHF 100K | i4L Innogrant for BiotherapeuticsUndisclosed | Biotech | Switzerland | Investors | |
Shield AICompany profile Shield AI develops autonomy software and uncrewed aircraft for military and defense customers. Shield AI develops autonomy software and uncrewed aircraft for military and defense customers. | $250M | Delayed-draw facility commitmentUndisclosed | Defense tech | United States | Investors Undisclosed | |
| MG M1X GlobalCompany profile Develops sovereign financial infrastructure and blockchain-based solutions for governments Develops sovereign financial infrastructure and blockchain-based solutions for governments | $3M | AngelUndisclosed | Fintech | United States | Investors | |
| NC Normal ComputingCompany profile Builds AI for the semiconductor industry and develops new class of computing hardware Builds AI for the semiconductor industry and develops new class of computing hardware | $50M | StrategicUndisclosed | Hardware | United States | Investors | |
| E Builds due diligence infrastructure for regulated markets | $8M | Pre-Seed+SeedUndisclosed | Fintech | United Kingdom | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · All time
- 1Innovate UK
Emerald, Go Eve, Nearhuman
39rounds0led - 2NVIDIA
Noeri, Applied Compute, Riverlane
32rounds1led - 3Bethnal Green Ventures
Excelas, HeyLina, Amytis
25rounds0led - 4Future of Health Grant
Healium, NeuroTreasure Solutions, Entrelacs
20rounds0led - 5Peak XV Partners
PowerUp Money, Hex, Meragi
19rounds3led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.